In mid-2009, Cougar’s tender offer expired (more than 20 billion shares or 95 percent of Cougar stock were tendered) and in May 2009, Johnson & Johnson acquired Cougar Biotechnology Inc. for about $893 million or $43 per share. This merger has recently been completed following large investments by Lindsay Rosenwald, MD, of Paramount BioSciences. Although [...]
Several of Dr. Rosenwald’s other companies in which he founded have became headline makers because of the treatment advances they have made. Among those companies are Sypress Biosciences with their Savella, useful in the treatment of fibromyalgia and another breakthrough from the same company is the Prosorba Column, used to treat severe rheumatoid arthritis. Other [...]
Lindsay Rosenwald started his professional research at Pennsylvania State University in 1973 after graduating from Abington High School. He excelled an enterprise and was particularly intrigued with economics and finance. In quest for his lifelong dream, Rosenwald entered Temple University’s University of Medicine. After graduating from Temple University in 1983, he began an internship at [...]